Hydroxyzine Pamoate Capsule
Product Images NDC 0555-0302
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Hydroxyzine Pamoate (NDC 0555-0302). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
Hydroxyzine Pamoate capsules USP 25mg, with NDC number 0555-0323-02 and GTIN number 0030550323020, come in a bottle of 100 capsules. Each capsule contains 25mg of hydroxyzine hydrochloride, equivalent to hydroxyzine pamodate USP. The full dosage information can be found in the package insert. The capsules should be stored at a controlled room temperature of 20°C to 25°C and dispensed in a tightly closed and light-resistant container as defined by the USP with a child-resistant closure. Its manufacturer is Teva Pharmaceuticals USA, Inc, located in North Wales, PA 19454.*
Image 3
Hydroxyzine Pamoate capsules USP, containing 50 mg of hycrazing pamodts, are packaged in white bottles labeled B onty containing 100 capsules. The GTIN number for the packaging is 0030550302025. The usual dosage and storage instructions are provided in the package insert. The medication should be dispensed in light-resistant containers with a child-resistant closure. The manufacturer is Teva Pharmaceuticals USA, Inc, located in North Wales, PA.*
Image 4
Each capsule of this medication contains 100 mg of hydroxyzine hydrochloride in the form of hydroxyzine pamoate, USP. Instructions on the typical dosage are available in the package insert provided. The medication should be stored at a temperature of 20° to 25°C (68° to 77°F) and in accordance with the USP Controlled Room Temperature regulations, in a tightly-sealed, light-resistant container with a child-resistant closure. It is essential to store the medication away from children. This medication is produced by Tewa Pharmaceuticals USA, Inc., in North Wales, PA 19454. This information is current as of the medication revision date, which was October 2019, and the non-machinery section does not contain any information.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.